CytomX Therapeutics, Inc. (CTMX)
2.98
+0.04
(+1.36%)
USD |
NASDAQ |
Jun 09, 16:00
2.99
+0.01
(+0.34%)
After-Hours: 04:25
CytomX Therapeutics Market Cap : 648.73M for June 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 64.70B |
| Ocugen, Inc. | 419.52M |
| Catalyst Pharmaceuticals, Inc. | 3.829B |
| Rigel Pharmaceuticals, Inc. | 567.75M |
| iBio, Inc. | 58.72M |
Market Cap Related Metrics
| PS Ratio | 13.45 |
| Price to Book Value | 2.028 |
| Price | 2.98 |
| Earnings Yield | -12.20% |